Dynamics and flexibility of G-protein-coupled receptor conformations and their relevance to drug design.

G-protein coupled receptors (GPCRs) are seven helical transmembrane proteins with functional diversity and form the largest superfamily of drug targets. The functional diversity of these receptors stems from the conformational flexibility of the receptor, the nature of the ligand activating the receptor, and the intracellular protein that the receptor couples to. A molecular level understanding of the influence of each of these factors will greatly aid the design of functional selective drugs. In this review, the current state of our understanding of the conformational flexibility and dynamics of class A GPCRs derived from a confluence of biophysical and computational techniques is elucidated.

[1]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[2]  Viktor Hornak,et al.  Helix Movement is Coupled to Displacement of the Second Extracellular Loop in Rhodopsin Activation , 2009, Nature Structural &Molecular Biology.

[3]  H Gobind Khorana,et al.  Rhodopsin structure, dynamics, and activation: a perspective from crystallography, site-directed spin labeling, sulfhydryl reactivity, and disulfide cross-linking. , 2003, Advances in protein chemistry.

[4]  R. Lefkowitz,et al.  Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways. , 2009, Developmental cell.

[5]  G. Schertler.  Structure of rhodopsin and the metarhodopsin I photointermediate. , 2005, Current opinion in structural biology.

[6]  Gerhard Hummer,et al.  Atomistic insights into rhodopsin activation from a dynamic model. , 2008, Journal of the American Chemical Society.

[7]  M. Lohse,et al.  Optical techniques to analyze real-time activation and signaling of G-protein-coupled receptors. , 2008, Trends in pharmacological sciences.

[8]  W. Weis,et al.  Structural insights into G-protein-coupled receptor activation. , 2008, Current opinion in structural biology.

[9]  Juan Jesús Pérez,et al.  BUNDLE: A program for building the transmembrane domains of G-protein-coupled receptors , 1998, J. Comput. Aided Mol. Des..

[10]  Xavier Deupi,et al.  Coupling ligand structure to specific conformational switches in the β2-adrenoceptor , 2006, Nature chemical biology.

[11]  T. Schwartz,et al.  Molecular mechanism of 7TM receptor activation--a global toggle switch model. , 2006, Annual review of pharmacology and toxicology.

[12]  Arthur Christopoulos,et al.  Functional Selectivity and Classical Concepts of Quantitative Pharmacology , 2007, Journal of Pharmacology and Experimental Therapeutics.

[13]  Harel Weinstein,et al.  Hallucinogen actions on 5-HT receptors reveal distinct mechanisms of activation and signaling by G protein-coupled receptors , 2005, The AAPS Journal.

[14]  R. Stevens,et al.  High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.

[15]  Markus Eilers,et al.  Changes in interhelical hydrogen bonding upon rhodopsin activation. , 2005, Journal of molecular biology.

[16]  Robert P. Millar,et al.  Functional Microdomains in G-protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[17]  R. Stevens,et al.  GPCR Engineering Yields High-Resolution Structural Insights into β2-Adrenergic Receptor Function , 2007, Science.

[18]  Christopher A Reynolds,et al.  Toward the active conformations of rhodopsin and the β2‐adrenergic receptor , 2004, Proteins.

[19]  Xavier Deupi,et al.  Probing the β2 Adrenoceptor Binding Site with Catechol Reveals Differences in Binding and Activation by Agonists and Partial Agonists* , 2005, Journal of Biological Chemistry.

[20]  Francesca Fanelli,et al.  Inactive and active states and supramolecular organization of GPCRs: insights from computational modeling , 2006, J. Comput. Aided Mol. Des..

[21]  Tsutomu Kouyama,et al.  Crystal structure of squid rhodopsin , 2008, Nature.

[22]  R. Mailman,et al.  Ligand functional selectivity advances our understanding of drug mechanisms and drug discovery , 2009, Neuropsychopharmacology.

[23]  Nagarajan Vaidehi,et al.  Modeling small molecule-compound binding to G-protein-coupled receptors. , 2009, Methods in enzymology.

[24]  Nagarajan Vaidehi,et al.  Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors. , 2008, Journal of molecular biology.

[25]  Gebhard F. X. Schertler,et al.  Structure of a β1-adrenergic G-protein-coupled receptor , 2008, Nature.

[26]  Alan Grossfield,et al.  Internal hydration increases during activation of the G-protein-coupled receptor rhodopsin. , 2008, Journal of molecular biology.

[27]  Oliver P. Ernst,et al.  Crystal structure of opsin in its G-protein-interacting conformation , 2008, Nature.

[28]  Steven O. Smith,et al.  Multiple switches in G protein-coupled receptor activation. , 2009, Trends in pharmacological sciences.

[29]  C. Tate,et al.  Engineering G protein-coupled receptors to facilitate their structure determination. , 2009, Current opinion in structural biology.

[30]  L. Pardo,et al.  Ligand-specific regulation of the extracellular surface of a G protein coupled receptor , 2009, Nature.

[31]  Nagarajan Vaidehi,et al.  Position of helical kinks in membrane protein crystal structures and the accuracy of computational prediction. , 2009, Journal of molecular graphics & modelling.

[32]  H. Khorana,et al.  Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.

[33]  N. Vaidehi,et al.  Structural insights into conformational stability of wild-type and mutant beta1-adrenergic receptor. , 2010, Biophysical journal.

[34]  Vadim Cherezov,et al.  A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. , 2008, Structure.

[35]  K. Jacobson,et al.  Development of selective high affinity antagonists, agonists, and radioligands for the P2Y1 receptor. , 2008, Combinatorial chemistry & high throughput screening.

[36]  Klaus Schulten,et al.  Molecular dynamics investigation of primary photoinduced events in the activation of rhodopsin. , 2002, Biophysical journal.

[37]  F Glaser,et al.  Modeling the 3D structure of GPCRs from sequence , 2001, Medicinal research reviews.

[38]  R. Stevens,et al.  The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.

[39]  A. Hirshfeld,et al.  Coupling of retinal isomerization to the activation of rhodopsin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Manfred Burghammer,et al.  Structure of bovine rhodopsin in a trigonal crystal form. , 2003, Journal of molecular biology.

[41]  V. Hornak,et al.  Light activation of rhodopsin: insights from molecular dynamics simulations guided by solid-state NMR distance restraints. , 2010, Journal of molecular biology.

[42]  Terry Kenakin,et al.  Ligand-selective receptor conformations revisited: the promise and the problem. , 2003, Trends in pharmacological sciences.

[43]  Nagarajan Vaidehi,et al.  Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation. , 2008, Biophysical journal.

[44]  R. Horuk,et al.  I want a new drug: G-protein-coupled receptors in drug development. , 2006, Drug discovery today.

[45]  H. Weinstein,et al.  Active State-like Conformational Elements in the β2-AR and a Photoactivated Intermediate of Rhodopsin Identified by Dynamic Properties of GPCRs† , 2008, Biochemistry.

[46]  Andrei L. Lomize,et al.  Structural organization of G-protein-coupled receptors , 1999, J. Comput. Aided Mol. Des..

[47]  Marta Filizola,et al.  Dynamic models of G-protein coupled receptor dimers: indications of asymmetry in the rhodopsin dimer from molecular dynamics simulations in a POPC bilayer , 2006, J. Comput. Aided Mol. Des..

[48]  Harel Weinstein,et al.  Three-dimensional representations of G protein-coupled receptor structures and mechanisms. , 2002, Methods in enzymology.

[49]  H. Weinstein,et al.  Structural And Dynamic Effects Of Cholesterol At Preferred Sites Of Interaction With Rhodopsin Identified From Microsecond Length Molecular Dynamics Simulations , 2009 .

[50]  Nagarajan Vaidehi,et al.  Computational mapping of the conformational transitions in agonist selective pathways of a G-protein coupled receptor. , 2010, Journal of the American Chemical Society.

[51]  R. Vogel,et al.  Rhodopsin Activation Switches in a Native Membrane Environment † , 2009, Photochemistry and photobiology.

[52]  G. Liapakis,et al.  Use of the substituted cysteine accessibility method to study the structure and function of G protein-coupled receptors. , 2002, Methods in enzymology.

[53]  Patrick Scheerer,et al.  Crystal structure of the ligand-free G-protein-coupled receptor opsin , 2008, Nature.

[54]  T. Mielke,et al.  Electron crystallography reveals the structure of metarhodopsin I , 2004, The EMBO journal.

[55]  P. Crozier,et al.  How a small change in retinal leads to G‐protein activation: Initial events suggested by molecular dynamics calculations , 2006, Proteins.

[56]  Ron O Dror,et al.  Identification of two distinct inactive conformations of the β2-adrenergic receptor reconciles structural and biochemical observations , 2009, Proceedings of the National Academy of Sciences.

[57]  J. Violin,et al.  β-Arrestin-biased ligands at seven-transmembrane receptors , 2007 .

[58]  J. Ballesteros,et al.  Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. , 2002, The Journal of biological chemistry.

[59]  Duan Yang,et al.  The evolution of transmembrane helix kinks and the structural diversity of G protein-coupled receptors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[60]  R. Lefkowitz,et al.  β-Arrestins and Cell Signaling , 2007 .

[61]  M. Bouvier,et al.  The evasive nature of drug efficacy: implications for drug discovery. , 2007, Trends in pharmacological sciences.

[62]  Xavier Deupi,et al.  Activation of G protein-coupled receptors. , 2007, Advances in protein chemistry.

[63]  B. Kobilka,et al.  New G-protein-coupled receptor crystal structures: insights and limitations. , 2008, Trends in pharmacological sciences.

[64]  Patricia H. Reggio,et al.  Computational methods in drug design: Modeling G protein-coupled receptor monomers, dimers, and oligomers , 2006, The AAPS Journal.

[65]  K. Schulten,et al.  Mechanism of signal propagation upon retinal isomerization: insights from molecular dynamics simulations of rhodopsin restrained by normal modes. , 2008, Biophysical journal.

[66]  Peter L. Freddolino,et al.  Prediction of structure and function of G protein-coupled receptors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[67]  S. Rasmussen,et al.  The structure and function of G-protein-coupled receptors , 2009, Nature.